Skip to main content

2023 Review Course Learning Objectives and CME

Intended Audience

The ASPHO Review Course is designed for physicians preparing for the American Board of Pediatrics (ABP) examination for initial certification in pediatric hematology/oncology as well as fellows in training and practitioners providing care for pediatric patients with cancer and blood disorders who are seeking a comprehensive review and update of key concepts in the field.

Learning Objectives

As a result of attending this course, participants should be able to

  1. describe the basic pathophysiology of hematologic disease and cancer in infants, children, and adolescents, including molecular and cellular biology, the genetic and biochemical basis of disease, and the fundamentals of morphology and disease classification
  2. discuss the differential diagnosis, management, and outcomes of the hematologic disorders and malignancies encountered in practice by pediatric hematology/oncology specialists
  3. explain fundamental concepts of biostatistics, epidemiology and outcomes analysis, and engagement in scholarly activities as these areas apply to the field of pediatric hematology/oncology
  4. analyze the principles and practice of stem cell transplantation, transfusion medicine, and supportive care in children with hematologic disease and cancer, along with the basic principles of immunology and the most common immunologic disorders encountered by the hematologist
  5. prepare for the hematology/oncology subboard examination offered by the ABP and subsequent MOCA-Peds requirements.

Continuing Medical Education (CME)

The American Society of Pediatric Hematology/Oncology (ASPHO) will offer CME credit for those sessions attended and evaluated. A certificate will be issued upon completion of the evaluation.

The American Society of Pediatric Hematology/Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Pediatric Hematology/Oncology designates this Other activity (blend of live and on-demand lectures) for a maximum of 33.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ASPHO offers its course evaluation in an online format that can be accessed by visiting https://apps.aspho.org/MyAccount. The online evaluation may be completed during or after the course. Participants receive their certificates immediately when they submit their evaluation. We encourage all attendees to complete their evaluation regardless of whether they are seeking CME credit.

Disclosure

ASPHO requires that all planners and presenters disclose the existence of all financial relationships they have had in the last 24 months with ineligible companies (defined as those whose primary business is producing, marketing, reselling, or distributing healthcare products used by or on patients). The ASPHO Accreditation Subcommittee of the Education Committee reviews all conflicts as submitted by planners and presenters and mitigates such conflicts to ensure the content of the activity is aligned with the interests of the public.

View the 2023 Review Course speaker, planner, reviewer, and staff disclosures here.

Disclaimer

The material presented in this activity represents the opinion of the speakers and not necessarily the views of ASPHO.